The Food and Drug Administration (FDA) has approved the first generic version of Venofer ® (iron sucrose) Injection.

(HealthDay News) — Many individuals who are not up to date with recommended vaccinations would accept vaccines if offered during an emergency department visit, according to research published in the ...

The ArteraAI Prostate Test is intended to assist clinicians and patients with risk-based decisions in localized prostate cancer.

This is the first randomized trial to investigate metastasis-directed therapy plus continuous androgen deprivation therapy for oligometastatic prostate cancer.

Magnetic stimulation plus bladder training and TTNS plus bladder training are both more effective than bladder training alone.

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.

(HealthDay News) — Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according to a study published ...

Observational study findings link dialysis dose reduction to worse postoperative patient survival.

Clinicians should carefully monitor manganese levels to avoid dysregulation in patients with chronic kidney disease (CKD).

Research links environmental exposures to CKD development and progression. Here’s what clinicians and patients need to know.

Disability insurance applications and appeals (18.6%).

The preferred treatment for gay and bisexual men with prostate cancer may differ according to preferred sexual behavior, an analysis suggests.